Measuring patient adherence to malaria treatment: A comparison of results from self-report and a customised electronic monitoring device

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Bruxvoort, Katia ^a,b   Festo, Charles ^b   Cairns, Matthew ^a   Kalolella, Admirabilis ^b   Mayaya, Frank ^b   Kachur, S Patrick ^c   Schellenberg, David ^a   Goodman, Catherine ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b IFAKARA HEALTH INSTITUTE   (Tanzania)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISIN; ARTEMISININ DERIVATIVE; LACTONE;

ARTICLE; BLISTER PACK; CHILD; CHILD HEALTH CARE; CONTROLLED STUDY; DRUG MONITORING; EQUIPMENT DESIGN; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALARIA; MALE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHARMACY; SELF REPORT; SMART BLISTER PACK; TANZANIA; TIME; TREATMENT DURATION; VALIDATION PROCESS; COMBINATION DRUG THERAPY; DEVICES; MALARIA, FALCIPARUM; PHYSIOLOGIC MONITORING; PRESCHOOL CHILD; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; LACTONES; MALARIA, FALCIPARUM; MALE; MEDICATION ADHERENCE; MONITORING, PHYSIOLOGIC; TANZANIA;

EID: 84941670921     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134275     Document Type: Article

References (38)

1. Souares A, Moulin P, Sarrassat S, Carlotti MP, Lalou R, Le Hesran JY. Self-reported data: A major tool to assess compliance with anti-malarial combination therapy among children in Senegal. Malar J. 2009; 8:257. Epub 2009/11/20. doi: 1475-2875-8-257 [pii]doi:10.1186/1475-2875-8-257 PMID: 19922609; PubMed Central PMCID: PMC2784475.
2. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. Journal of acquired immune deficiency syndromes. 2006; 43 Suppl 1:S79-S87. doi: 10.1097/01.qai. 0000248337.97814.66 PMID: 17133207; PubMed Central PMCID: PMC2866146.
3. Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: A summary of the literature. Medical care. 2004; 42(7):649-52. PMID: 15213489.
4. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353(5):487-97doi:10.1056/NEJMra050100PMID: 16079372.
5. Bruxvoort K, Goodman C, Kachur SP, Schellenberg D. How patients take malaria treatment: A systematic review of the literature on adherence to antimalarial drugs. PLoS One. 2014; 9(1):e84555. doi:10.1371/journal.pone.0084555 PMID: 24465418.
6. Banek K, Lalani M, Staedke SG, Chandramohan D. Adherence to artemisinin-based combination therapy for the treatment of malaria: A systematic review of the evidence. Malar J. 2014; 13(1):7. doi:10.1186/1475-2875-13-7 PMID: 24386988.
7. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical therapeutics. 1999; 21(6):1074-90; discussion 3. doi:10.1016/S0149-2918(99)80026-5PMID: 10440628.
8. Bell DJ, Wootton D, Mukaka M, Montgomery J, Kayange N, Chimpeni P, et al. Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. Malar J. 2009; 8:204. Epub 2009/08/28. doi: 1475-2875-8-204 [pii]doi:10.1186/1475-2875-8-204 PMID: 19709418; PubMed Central PMCID: PMC2744923.
9. Twagirumukiza M, Kayumba PC, Kips JG, Vrijens B, Stichele RV, Vervaet C, et al. Evaluation of medication adherence methods in the treatment of malaria in Rwandan infants. Malar J. 2010; 9:206. Epub 2010/07/20. doi: 1475-2875-9-206 [pii]doi:10.1186/1475-2875-9-206 PMID: 20637094; PubMed Central PMCID: PMC2912926.
10. van den Boogaard J, Lyimo RA, Boeree MJ, Kibiki GS, Aarnoutse RE. Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: A pilot study. Bull World Health Organ. 2011; 89(9):632-9. doi:10.2471/BLT.11.086462 PMID: 21897483; PubMed Central PMCID: PMC3165976.
11. Bell DJ, Kapitao Y, Sikwese R, van Oosterhout JJ, Lalloo DG. Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi. Journal of acquired immune deficiency syndromes. 2007; 45(5):560-3. doi:10.1097/QAI.0b013e3180decadb PMID: 17558333.
12. Price RN, Uhlemann AC, van Vugt M, Brockman A, Hutagalung R, Nair S, et al. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin Infect Dis. 2006; 42(11):1570-7. doi:10.1086/503423 PMID: 16652314.
13. White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, et al. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar J. 2009; 8:253. Epub 2009/11/13. doi: 1475-2875-8-253 [pii]doi:10.1186/1475-2875-8-253PMID: 19906307; PubMed Central PMCID: PMC2784792.
14. Barnes KI, Watkins WM, White NJ. Antimalarial dosing regimens and drug resistance. Trends Parasitol. 2008; 24(3):127-34. doi:10.1016/j.pt.2007.11.008 PMID: 18262470.
15. Fuangchan A, Dhippayom T, Kongkaew C. Intervention to promote patients' adherence to antimalarial medication: A systematic review. Am J Trop Med Hyg. 2014; 90(1):11-9. doi:10.4269/ajtmh.12-0598 PMID: 24166045; PubMed Central PMCID: PMC3886405.
16. National Bureau of Statistics (NBS) [Tanzania] and ICF Macro. Tanzania Demographic and Health Survey 2010. Dar es Salaam, Tanzania: NBS and ICF Macro, 2011.
17. Tanzania Commission for AIDS (TACAIDS) ZACZ, National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OGS), and Macro International Inc., . Tanzania HIV/AIDS and Malaria Indicator Survey 2011-12. Dar es Salaam, Tanzania: TACAIDS, ZAC, NBS, OCGS, and Macro International Inc., 2012.
18. United Republic of Tanzania Ministry of Health and Social Welfare. National Guidelines for Diagnosis and Treatment of Malaria. Dar es Salaam, Tanzania: National Malaria Control Program, 2011.
19. AMFm Independent Evaluation Team. Independent Evaluation of Phase 1 of the Affordable Medicines Facility-malaria (AMFm), Multi-Country Independent Evaluation Report: Final Report. Calverton, Maryland and London: ICF International and London School of Hygiene and Tropical Medicine, 2012.
20. Rutta E, Senauer K, Johnson K, Adeya G, Mbwasi R, Liana J, et al. Creating a new class of pharmaceutical services provider for underserved areas: The Tanzania accredited drug dispensing outlet experience. Progress in community health partnerships: Research, education, and action. 2009; 3(2):145-53. doi:10.1353/cpr.0.0063PMID: 20208262.
21. Rutta E, Kibassa B, McKinnon B, Liana J, Mbwasi R, Mlaki W, et al. Increasing Access to Subsidized Artemisinin-based Combination Therapy through Accredited Drug Dispensing Outlets in Tanzania. Health Res Policy Syst. 2011; 9:22. Epub 2011/06/11. doi: 1478-4505-9-22 [pii]doi:10.1186/1478-4505-9-22 PMID: 21658259; PubMed Central PMCID: PMC3141785.
22. Bruxvoort K, Festo C, Kalolella A, Cairns M, Lyaruu P, Kenani M, et al. Cluster Randomized Trial of Text Message Reminders to Retail Staff in Tanzanian Drug Shops Dispensing Artemether-Lumefantrine: Effect on Dispenser Knowledge and Patient Adherence. Am J Trop Med Hyg. 2014; 91:844-53doi:10.4269/ajtmh.14-0126PMID: 25002300.
23. Bruxvoort K, Kalolella A, Cairns M, Festo C, Kenani M, Lyaruu P, et al. Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy? Malar J. 2015; 14(1):87doi:10.1186/s12936-015-0602-x PMID: 25889767; PubMed Central PMCID: PMC4340668.
24. Jones SR, Carley S, Harrison M. An introduction to power and sample size estimation. Emergency medicine journal: EMJ. 2003; 20(5):453-8. PMID: 12954688; PubMed Central PMCID: PMC1726174.
25. Yeung S, White NJ. How do patients use antimalarial drugs? A review of the evidence. Trop Med Int Health. 2005; 10(2):121-38. Epub 2005/02/01. doi: TMI1364 [pii]doi:10.1111/j.1365-3156.2004.01364.x PMID: 15679555.
26. Ezzet F, Mull R, Karbwang J. Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. Br J Clin Pharmacol. 1998; 46(6):553-61. PMID: 9862244; PubMed Central PMCID: PMC1873796.
27. Taneja I, Erukala M, Raju KS, Singh SP, Wahajuddin. Dried blood spots in bioanalysis of antimalarials: Relevance and challenges in quantitative assessment of antimalarial drugs. Bioanalysis. 2013; 5 (17):2171-86. doi:10.4155/bio.13.180 PMID: 23962252.
28. Fogg C, Bajunirwe F, Piola P, Biraro S, Checchi F, Kiguli J, et al. Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J Trop Med Hyg. 2004; 71(5):525-30. Epub 2004/12/01. doi:71/5/525 [pii]. PMID: 15569777.
29. Rahman MM, Dondorp AM, Day NP, Lindegardh N, Imwong M, Faiz MA, et al. Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: A randomised controlled trial. Trans R Soc Trop Med Hyg. 2008; 102(9):861-7. Epub 2008/07/09. doi: S0035-9203(08)00254-X [pii]doi:10.1016/j.trstmh.2008.05.022 PMID: 18606428.
30. Simba DO, Kakoko D, Tomson G, Premji Z, Petzold M, Mahindi M, et al. Adherence to artemether/lumefantrine treatment in children under real-life situations in rural Tanzania. Trans R Soc Trop Med Hyg. 2012; 106(1):3-9. Epub 2011/11/22. doi: S0035-9203(11)00191-X [pii]doi:10.1016/j.trstmh.2011.09.006 PMID: 22099005.
31. Faucher JF, Aubouy A, Adeothy A, Cottrell G, Doritchamou J, Gourmel B, et al. Comparison of sulfadoxine- pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: A randomized effectiveness noninferiority trial. J Infect Dis. 2009; 200(1):57-65. Epub 2009/05/28. doi:10.1086/599378 PMID: 19469703.
32. Ngasala BE, Malmberg M, Carlsson AM, Ferreira PE, Petzold MG, Blessborn D, et al. Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children <5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: A randomized trial. Clin Infect Dis. 2011; 52(7):873-82. Epub 2011/03/24. doi: cir066 [pii]doi:10.1093/cid/cir066 PMID: 21427394.
33. Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, et al. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: A randomised trial. Lancet. 2005; 365(9469):1467-73. Epub 2005/04/27. doi:S0140-6736(05)66416-1 [pii]doi: 10.1016/S0140-6736(05)66416-1 PMID: 15850630.
34. Ezzet F, van Vugt M, Nosten F, Looareesuwan S, White NJ. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob Agents Chemother. 2000; 44 (3):697-704. PMID: 10681341; PubMed Central PMCID: PMC89749.
35. Checchi F, Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, et al. Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda. Malar J. 2006; 5:59. doi:10.1186/1475-2875-5-59 PMID: 16854236; PubMed Central PMCID: PMC1543643.
36. Tarning J, McGready R, Lindegardh N, Ashley EA, Pimanpanarak M, Kamanikom B, et al. Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria. Antimicrob Agents Chemother. 2009; 53(9):3837-46. doi:10.1128/AAC.00195-09 PMID: 19564366; PubMed Central PMCID: PMC2737887.
37. Lefevre G, Looareesuwan S, Treeprasertsuk S, Krudsood S, Silachamroon U, Gathmann I, et al. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg. 2001; 64(5-6):247-56. PMID: 11463111.
38. van Vugt M, Wilairatana P, Gemperli B, Gathmann I, Phaipun L, Brockman A, et al. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. Am J Trop Med Hyg. 1999; 60(6):936-42. PMID: 10403324.